Peer-reviewed journal articles |
Year |
Month |
| Courneya, KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JKH, Lane K, Yasui Y, McKenzie DC. Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial. Journal of Clinical Oncology, Oct 1;25(28):1-9, 2007 |
2007 |
Oct |
| Karvinen KH, Courneya KS, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS. Correlates of exercise motivation and behavior in a population-based sample of endometrial cancer survivors: An applicaiton of the Theory of Planned Behavior. International Journal of Behavioral Nutrition and Physical Activity 4:21(May2007)1479-1568 |
2007 |
May |
| Campbell KL, Westerlind KC, Harber VJ, Bell GJ Mackey JR,, Courneya KS. Effects of an aerobic exercise intervention on estrogen metabolism in premenopausal women: A randomized controlled trial. Cancer Epidemiol Biomarkers Prevention. Apr;16(4):731-9, 2007 |
2007 |
Apr |
| Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lanke K, Segal RJ. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy. Med Sci Sports Exerc 39, S63, 2007 |
2007 |
|
| Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol, 50(15);1435-41, 2007 |
2007 |
|
| Verma S, Wong NS, Trudeau M, Joy A, Mackey J, Dranitsaris G, Clemons M. Survival differences observed in metasttic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracyclines and taxane. Am J Clin Oncolo 30(3):297-302, 2007 |
2007 |
|
| Vallance, JKH, Courneya, KS, Plotnikorr, RC, Dinu, I, & Mackey, JR. Maintenance of physical activity in breast cancer survivors after a randomized trial. Medicine & Science in Sprots & Exercise, in press, 2007 |
2007 |
|
| Courneya Kerry S, Segal Roanne J, Gelmon Karen, Reid Robert D, Mackey John R, Friedenreich Christine M, Proulx Caroline, Kirsten Lane, Aliya B. Ladha, Jeffrey K Vallance, Yutaka Yasui, Donald C McKenzie. Six-month follow-up of patient-rated outcomes in a Randomized Controlled Trial of Exercise Training during Breast Cancer Chemotherapy. Cancer Epidemiology, Biomarkers and Prevention, in press 2007 |
2007 |
|
| Jones LW, Haykowsky M, Pituskin EN, Jendzjowsky NG, Tomczak CR, haennel RG, Mackey JR. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor-positive operable breast cancer. The Oncologist, 12(10), 1156-64, 2007 |
2007 |
|
| Piccart-Gebhart M, Burzykowski T, Buyse M, Sledge G, Carmichael J, Hans-Joachim L, Mackey J, Nabholtz J, Paridaens R, Biganzoli L, Jassem J, Bontenbal M,Bonneterre J, Chan S, Basaran Atalay G, Therasse P. Effects of taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic cancer. J Clin Oncol, in press, 2007 |
2007 |
|
| Vallance JKH, Courneya KS, Plotnikoff RC, Mackey JR. Analyzing Theoretical Mechanisms of Physical Activity Behavior Change in Breast Cancer Survivors: Results for the Activity Promotion (ACTION) Trial. Annals of Behavioral Medicine, in press 2007 |
2007 |
|
| Courneya KS, McKenzie DC, Reid RD, Mackey JR, Gelmon K, Friedenreich CM, Ladha AB, Proulx C, Lane K, Vallance JK, Segal RJ. Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy. Annals of Behavioral Medicine, in press, 2007 |
2007 |
|
| Burzkowski T, Buyse M, Piccart-Gebhart M, Sledge G, Carmichael J, Hans-Joachim Luck, Mackey J, Nabholtz JM, Paridaens R, Biganzoli L, Jassem J, Bontenbal M, Bonneterre J, Chan S, Basaran G, Therasse P. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate endpoints in metastatic breast cancer. J Clin Oncol, in press, 2007 |
2007 |
|
| Eastell R, Adams JE, Coleman R, Howell A, Hannon RA, Cuzick J, Mackey JR, Beckmann M, Clack G. Effect of Anastrozole on Bone Mineral Density: 5-year Results from the ATAC Trial (18233230) J Clin Oncol, in press, 2007 |
2007 |
|
| Stevinson C, Faught W, Steed H, Tonkin K, Ladhaa B, Vallance JK, Capstick V, Schepansky A, Courneya KS. Associates between physical activity and quality of life in ovarian cancer survivors. Gynecologic Oncology 106:244-250. 2007 |
2007 |
|
| Vallance, JKH, Courneya, KS, Plotnikoff, RC, Yasui, Y, & Mackey, JR Effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors: A randomized controlled trial. J Clin Oncol, 25(17):2352-9, 2007 |
2007 |
|
| Jones LW, Eves ND, Mackey
| 2007 |
|
| Verma S, Joy AA, Mackey JR,, Dranitanis G, Trudeau M, Clemons M. Survival differences observed in anthracyclines and taxane refractory metastatic breast cancer patients treated with capecitabine when compared with vinorelbine. American Journal of Clinical ONcology. 30(3), 297-302, 2007 |
2007 |
|
| Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, McKenzie DC. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol, 25(28) 4396-404, 2007 |
2007 |
|
| Jones LW, Haykowsky M, Peddle C. Joy AA, Pituskin E, Tkachuk L, Courneya K, Mackey J. Cardiovascular risk profile of HER2/neu positive breast cancer patients treated with anthracycline-taxane containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol Biomarkers Prev 2007;16(5):1026-31 |
2007 |
|
| Kumar P, Mercer J, Doerkson C, Tonkin K, McEwan A. Clinical production, stability studies and PET imaging with 16-a18f fluoroestradiol (18F FES) in ER positive breast cancer patients. J Pharm Pharmaceut Sci (www.cspsCanada.org) 10(2):256s-265s, 2007 |
2007 |
|
| Findlay B, Tonkin K, Crump M, Norris B, Trudeau M, Blackstein M, Burnell M, Skillings J, Bowman D, Walde D, Levine M, Pritchard KI, Palmer MJ, Tu D, Shepherd L. A dose escalation trial of adjuvant cyclophosphamide and andepirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes. Annals of Oncology 2007 18(10):1646-1651 |
2007 |
|
| Glemon KA, Mackey J, Verma S, Gertler SZ, Bangemann N, Klimo P, Scneeweiss A, Bremer K, Soulieres D, Tonkin K, Bell R, Heinrich B, Greiner D, Dias R. Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories. Clin Breast Cancer. Apr;5(1):52-8, 2004 |
2006 |
Apr |
| Courneya K, Jones LW, Mackey JR, Fairey AS. Exercise beliefs of breast cancer survivors before and after participation in a randomized controlled trial. International Journal of Behavioral Medicine, in press |
2006 |
|
| Vallance JKH, Courneya KS, Taylor LM, Plotnikoff RC, Mackey JR. Development and evaluation of a theory-based physical activity guidebook for breast cancer survivors. Health Education and Behavior, in press |
2006 |
|
| McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya, KS. A systematic review and meta-analysis of exercise interventions in breast cancer patients and survivors. Canadian Medical Association Journal, 175(1):34-41 |
2006 |
|
| Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR, Abdulkarim B. Prognostic significance of HER-2 positivity on the incidence of brain metastasis in newly diagnosed breast cancer. In press, Journal of Clinical Oncology |
2006 |
|
| Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 98(4):1534-40, 2005. |
2006 |
|
| Joy AA, Mackey JR. Adjuvant trastuzumab: progress, controversies, and the steps ahead. Current Oncology, 2006; volume 13, number 1. |
2006 |
|
| Martin M, Pienkowski T, Mackey JR, Pawlick M, Guastalla J-P, Weaver C, Tomiak E, Al-Tweigeri T,Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwel B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C. A randomized trial of docetaxel in combination with doxorubicin and cyclophosphamide (TAC) as adjuvant treatment of operable node-positive breast cancer. In press, New England Journal of Medicine, May, 2005. |
2005 |
May |
| Adjuvant and neoadjuvant use of high dose mitoxantrone, vinblastine, cyclophosphamide and autologous stem cell transplantation for stage III breast cancer. DA Stewart, P Brasher, AHG Paterson, P Geggie, JD Ruether, J Russell, P Craighead, M Smylie, JR Mackey. Annals of Oncology, in press, 2005 |
2005 |
|
| Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, St Martin B. Mackey JR. Effect of Exercise Training on C-Reactive Protein in Postmenopausal Breast Cancer Survivors: A Randomized Controlled Trial. Brain, Behavior, and Immunity, in press, 2005 |
2005 |
|
| Courneya K, Jones L, Mackey JR. Physical activity in cancer survivors: implications for recurrence and mortality. Cancer Therapy, in press 2005 |
2005 |
|
| Mackey JR, Joy AA. Skeletal health in survivors of postmenopausal breast cancer. International Journal of Cancer, 114(6): 1010-5, 2005 |
2005 |
|
| Cuzick J, Buzdar A, Baum M, Bianco R, Coleman R, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, Mackey J, Sainsbury R, Tobia J. Adjuvant use of anastrozole in breast cancer. Journal of Clinical Oncology, 22(8): 1524-6, 2004. |
2005 |
|
| Glemon KA, Mackey J, Verma S, Gertler SZ, Bangemann N, Klimo P, Scneeweiss A, Bremer K, Soulieres D, Tonkin K, Bell R, Heinrich B, Grenier D, Dias R. Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories. Clin Breast Cancer. Apr; 5(1): 52-8, 2004 |
2005 |
|
| Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 98 (4): 1534-40, 2005 |
2005 |
|
| Galmarini CM, Cros E, Graham K, Thomas X, Mackey JR, Dumontet C. Nucleotidase MRNA levels in Blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine. Haematologica, 89(5): 617-619, 2004. |
2004 |
|
| Cuzick J, Buzdar A, Baum M, Bianco R, Coleman R, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, Mackey J, Sainsbury R, Tobia J. Adjuvant use of anastrozole in breast cancer. Journal of Clinical Oncology, 22(8): 1524-6, 2004. |
2004 |
|
| Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A, Mackey JR, Wishart D, Greiner R, Zanke B. Predictive models for breast cancer susceptibility from multiple, single nucleotide polymorphisms. Clin Cancer Research, 10(8): 2725-37, 2004. |
2004 |
|
| Gelmon KA, Mackey JR, Verma S, Gertler SZ, Bangemann N, Klimo P, Schneeweiss A, Bremer K, Soulieres D, Tonkin K, Bell R, MacDonald P, Heinrich B, Grenier D, Dias R. The use of trastuzumab beyond disease progression: observations from a retrospective review of case histories. Clinical Breast Cancer, 5(1): 52-8, 2004. |
2004 |
|
| Cuzick J, Buzdar A, Baum M, Bianco R, Coleman R, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, Mackey J, Sainsbury R, Tobia J. Adjuvant use of anastrozole in breast cancer. Journal of Clinical Oncology, 22(8): 1524-6, 2004 |
2004 |
|
|
